Kaposi's sarcoma in HTV-infected patients: Treatment options

HIV Medicine

Volumn 1, Issue 3, 2000, Pages 137-142

  Hermans, P ^a  

^a SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

Author keywords

AIDS; Angiogenesis; HHV 8; HIV; Kaposi's sarcoma; Malignancies; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT;

AIDS RELATED COMPLEX; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; KAPOSI SARCOMA; REVIEW; SKIN TUMOR;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTINEOPLASTIC AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTIVIRAL AGENTS; HIV-1; HUMAN; SARCOMA, KAPOSI; SKIN NEOPLASMS;

EID: 0034232208     PISSN: 14642662     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1293.2000.00027.x     Document Type: Article

References (43)

1. Herndier BG, Kaplan LD, McGrath MS. Pathogenesis of AIDS lymphomas. AIDS 1994; 8: 1025-1049.
2. Johnson JC, Burnett AR, Willet GD, Young MA, Doninger J. High frequency of latent and clinical human papillomarvirus cervical infections in immunocompromised human immunodeficiency virus infected women. Obstet Gynecol 1992; 79: 321-327.
3. Gaidano G, Pastore C, Gloghini A, etal Distribution of human herpesvirus-8 sequence throughout the spectrum of AIDSrelated neoplasia. AIDS 1996; 10: 941-950.
4. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266: 1865-1869.
5. Noel JC, André J, Hermans P, ef al Kaposi's sarcoma: evaluation of the role of human papillomaviruses. A study using the high sensitive hot-start polymerase chain reaction detection method and a review of the literature. Arch Dermatol Res 1996; 288: 786-788.
6. Noel JC, Hermans P, André J, er al. Herpes virus-like DNA sequences and Kaposi's sarcoma: relationship with epidemiologic forms, clinical spectrum and histological features. Cancer 1996; 77: 2132-2136.
7. Hermans P. Opportunistic AIDS-associated malignancies in HIV-infected patients. Biomed Pharmacother 2000; 54: 32-40.
8. Dupin N, Rubin de Cervens V, Gorin I, ef al The influence of HAART on AIDS-associated KS. Br J Dermatol 1999; 140: 875-881.
9. Boshoff C, Whitby D, Hatziioannou T, et al. Kaposi's sarcomaassociated herpesvirus in HIV-negative Kaposi's sarcoma. Lancet 1995; 345: 1043-1044.
10. Gao SJ, Kingsley L, Li M, et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 1996; 8: 925-928.
11. Giraldo G, Beth E, Haguenau F. Herpes-type particles in tissue culture of Kaposi's sarcoma from different geographic regions. J Natl Cancer Inst 1972; 49: 1509-1526.
12. Euro-shaks European Study on HIV-associated Kaposi's sarcoma (Euro-Shaks Worshop, Barcelona 4-5 June 1998) Casabona J, ed. Spain, CEESCAT Hospital Universitari Germans Trias i Pujol, Badalona, 1998.
13. Bailey J, Pluda JM, Foil A, et al. Phase I/II study of intermittent all-trans retinoic acid alone and in combination with interferon alpha-2a in patients with epidemic Kaposi's sarcoma. J Clin Oncol 1995; 13: 1966-1974.
14. Tulpule A, Scaden DT, Espina BM, et al Results of a randomized study of IM862 in the treament of AIDS-related KS. JClin Oncol 2000; 18: 716-722.
15. Friedman-Kien A, Laubstein L, Marmor M. Kaposi's sarcoma and Pneumocystis carinii pneumonia among homosexual men, New York City and California. A/AflVK 1981; 2: 305-308.
16. Casabona J, Melbye M, Biggar RJ. Kaposi's sarcoma and nonHodgkin's Lymphoma in European AIDS cases. No excess risk of Kaposi's sarcoma in Mediterranean countries. Int J Cancer 1991;47:49-53.
17. Hermans P. Epidemiology, etiology and pathogenesis, clinical presentations and therapeutic approaches in Kaposi's Sarcoma: 15 year lessons from AIDS. Biomed Pharmacother 1998; 52: 440-446.
18. Hermans P, Lundgren J, Sommereijns B, Clumeck N and The AIDS in Europe Study Group. Epidemiology and survival of AIDS patients with Kaposi's sarcoma. AIDS Res Hum Retrovirol 1994; 10 (Suppl.): S78.
19. Hermans P, Lundgren JD, Sommereijns B, et al. for the AIDS in Europe Study Group. Epidemiology of AIDS related Kaposi's sarcoma in Europe over 10 years. AIDS 1996; 10: 911-917.
20. Hermans P, Mocroft A, Sommereijns B, et al. Epidemiology of AIDS-KS and protective effects of HAART: the EuroSIDA Study. 7th European Conference on Clinical Aspects and Treatment of HIV-Infection, Lisbon, Portugal, 23-27 October [abstract 898], 1999.
21. Ensoli B, Barillari B, Salahuddin SZ, Gallo RC, Wong Staal F. Tatprotein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 1990; 345:84-86.
22. Ensoli B, Gallo RC. Pathogenesis of AIDS-associated Kaposi's Sarcoma. Hematol Oncol Clin North Am 1991; 5: 281-295.
23. Ensoli B, Nakamura S, Salahuddin SZ, et al. AIDS Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science 1989; 243: 223-226.
24. Gill PS, Tsai YC, Rao AP, et al. Evidence of multiclonality in multicentric Kaposi's sarcoma. Proc Natl Acad Sei 1998; 95: 8257-8261.
25. Rabkin CS, Bedi G, Musaba E, eraJ. Aids-related Kaposi's sarcoma is a clonal neoplasm. Clin CancerRes 1995; 1:257-260.
26. Browning PJ, Sechler JMG, Kaplan M, et al. Identification and culture of Kaposi's sarcoma-like spindle cells from peripheral blood of HIV-1 infected individuals and normal controls. Blood 1994; 84: 2711-2716.
27. Castagliola D for the CISIH'. Trends in incidence of clinical manifestations of HIV infection and antiretroviral prescriptions in French University Hospitals. 6th European Conference on Clinical Aspects and Treatment of HIV-Infection, Hamburg, October 11-15, 1997.
28. Lunardi-Iskandar Y, Bryant JL, Zeman RA, et al. A pregnancy hormone human chorionic gonadotropin blocks tumorigenesis and metastasis of Kaposi's sarcoma cells (KS Y-l) in immunodeficient mice. Nature 1995; 375: 64-68.
29. Lunardi-Iskandar Y, Zeman RA, Lam VH, et al. Kaposi's sarcoma in pregnant women. Nature 1995; 377: 22.
30. Lunardi-Iskandar Y, Bryant JL, Blattner WA, et al. Effects of urinary factore from women in early pregnancy on HIV-1, SIV and associated disease. Nat Med 1998; 4: 428-434.
31. Gill PS, Lunardi-Iskandar Y, Louie SL, et al Human chorionic gonadotropin has antitumor activity in AIDS-related Kaposi's sarcoma. N EnglJ Med 1996; 17: 1261-1268.
32. Hermans P, Clumeck N, Picard 0, et al. Response of visceral AIDS-related Kaposi's sarcoma to Human Chorionic Gonadotropin. J Hum Viral 1998; 2: 82-88.
33. Hermans P, Franchioly P, Thioux C, Gray SJ, Vannerom H, Clumeck N. Possible role of granulocyte-macrophage colony stimulating factor (GM-CSF) on the rapid progression of AIDSrelated Kaposi's sarcoma lesions in vivo. BrJ Haematol 1994; 345: 84-86.
34. Kachra Z, Guo VVX, Sairam MR, Antakly T. Low molecular weight components but not dimeric HCG inhibit growth and down-regulate AP-1 transcription factor in Kaposi's sarcoma cells. Endocrinology 1997; 138: 4038-4041.
35. Ziegler JL. Endemic Kaposi's sarcoma in Africa and local volcanic soils, lancer 1993; 342: 1348-1351.
36. Simonart T, Noel JC, Andrei G, et al. Iron as a potential cofactor in the pathogenesis of Kaposi's sarcoma? Int J Cancer 1998; 78: 720-726.
37. Hermans P, Lundgren J, Sommereijns B, et al. for the AIDS in EUROPE Study Group. Survival of European patients with Kaposi's sarcoma as an AIDS defining condition during the first decade of AIDS. AIDS 1997; 11:525-531.
38. Gill PS, Rarick M, McCutchan JA, et al. Systemic treatment of AIDS-related Kaposi's sarcoma: results of a randomized trial. Am J Med 1991; 90: 427-433.
39. Gill PS, Tulpule A, Espina BM, et al. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma. J Clin Oncol 1999; 17: 1876-1883.
40. Saville MW, Lietzan J, Pluda J, et al. A phase II trial of Paclitaxel (Taxols) in patients with HIV-associated Kaposi's sarcoma. AIDS Res Hum Retrovirol 1994; 10 (Suppl.): S103.
41. Selik RM, Chu SY, Ward JW. Trends in infectious diseases and cancers among persons dying of HIV infection in the United States from 1987 to 1992. Ann Intern Med 1995; 123: 933936.
42. Mocroft A, Youle M, Gazzard B, Morcinek J, Halai R, Phillips AN. Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group. AIDS 1996; 10: 1101-1105.
43. Glesby MJ, Hoover DR, Weng S, et al. Use of antiherpes drugs and the risk of Kaposi's sarcoma: data from the Multicenter AIDS Cohort Study. J Infect Dis 1996; 173: 1477-1480.